CIBC Private Wealth Group LLC cut its stake in Morgan Stanley (NYSE:MS) by 15.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,466 shares of the financial services provider’s stock after selling 4,415 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Morgan Stanley were worth $970,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of the business. CWM LLC grew its position in shares of Morgan Stanley by 72.6% in the 4th quarter. CWM LLC now owns 799 shares of the financial services provider’s stock worth $32,000 after buying an additional 336 shares during the period. San Francisco Sentry Investment Group CA grew its position in shares of Morgan Stanley by 63.7% in the 4th quarter. San Francisco Sentry Investment Group CA now owns 1,002 shares of the financial services provider’s stock worth $39,000 after buying an additional 390 shares during the period. Vigilant Capital Management LLC grew its position in shares of Morgan Stanley by 183.8% in the 4th quarter. Vigilant Capital Management LLC now owns 1,158 shares of the financial services provider’s stock worth $46,000 after buying an additional 750 shares during the period. Signet Investment Advisory Group Inc. purchased a new stake in shares of Morgan Stanley in the 4th quarter worth about $59,000. Finally, Girard Partners LTD. purchased a new stake in shares of Morgan Stanley in the 3rd quarter worth about $115,000. Institutional investors and hedge funds own 85.67% of the company’s stock.
Shares of MS stock opened at $42.16 on Wednesday. Morgan Stanley has a one year low of $36.74 and a one year high of $59.38. The stock has a market cap of $71.33 billion, a P/E ratio of 9.15, a PEG ratio of 0.72 and a beta of 1.20. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 2.67.
Morgan Stanley (NYSE:MS) last posted its earnings results on Thursday, January 17th. The financial services provider reported $0.73 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.90 by ($0.17). The company had revenue of $8.55 billion for the quarter, compared to the consensus estimate of $9.32 billion. Morgan Stanley had a net margin of 17.43% and a return on equity of 12.08%. Morgan Stanley’s revenue was down 10.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.84 EPS. On average, analysts forecast that Morgan Stanley will post 4.99 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Friday, February 15th. Shareholders of record on Thursday, January 31st were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 2.85%. The ex-dividend date of this dividend was Wednesday, January 30th. Morgan Stanley’s dividend payout ratio is currently 26.03%.
MS has been the topic of a number of recent research reports. Societe Generale downgraded shares of Morgan Stanley from a “hold” rating to a “sell” rating in a research report on Friday, February 1st. Zacks Investment Research downgraded shares of Morgan Stanley from a “buy” rating to a “hold” rating in a research report on Wednesday, November 21st. Barclays reduced their target price on shares of Morgan Stanley from $63.00 to $55.00 and set an “equal weight” rating on the stock in a research report on Wednesday, January 2nd. BMO Capital Markets cut their price objective on shares of Morgan Stanley to $65.00 and set an “outperform” rating on the stock in a research report on Friday, January 18th. Finally, Wells Fargo & Co raised shares of Morgan Stanley to a “buy ms” rating in a research report on Thursday, December 20th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $56.38.
In other Morgan Stanley news, insider Jeffrey S. Brodsky sold 15,565 shares of the company’s stock in a transaction dated Friday, January 18th. The shares were sold at an average price of $43.38, for a total transaction of $675,209.70. Following the transaction, the insider now owns 112,420 shares in the company, valued at approximately $4,876,779.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: “CIBC Private Wealth Group LLC Decreases Holdings in Morgan Stanley (MS)” was published by Zolmax and is owned by of Zolmax. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://zolmax.com/investing/cibc-private-wealth-group-llc-decreases-holdings-in-morgan-stanley-ms/2913321.html.
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates Institutional Securities, Wealth Management, and Investment Management segments.
Read More: Marijuana Stocks
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.